$WELL

WELL Maintained by Evercore ISI Group -- Price Target Lowered to

Evercore ISI Group maintained its 'Outperform' rating for Welltower (WELL) but lowered its price target from $260.00 to $256.00. The company's GF Value™ suggests it is 14.8% overvalued at its current price of $232.54. Welltower, a global healthcare REIT, has a GF Score™ of 84/100, indicating strong performance. Insiders have recently bought $2.41 million in shares.

Original reporting
Published Sep 21, 2026, 5:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 5:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$WELL
Neutral
medium confidence
Mentioned
$WELL
Relevance
5/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$WELLNeutralLow
01

Why it matters

Analyst maintains confidence but trims target, suggesting modest risk‑adjusted downside.

02

Market read

A small target reduction may influence short‑term trading but is unlikely to drive major market moves.

03

What to watch

Insider buying of $2.4 M and strong GF Score may offset valuation concerns.

Relevance 5/10Novelty 5/10Timing: Oct 10 2023

Background

Welltower is the largest healthcare REIT, with a market cap of ~$168 B and a current share price of $232.54.

Company-level read

Ticker impact

$WELLNeutralMedium confidence
Context

Evercore ISI Group maintained an Outperform rating on WELL and lowered the price target to $256 on Oct 10, 2023.

Expected impact

Potential slight downside pressure as target falls 1.5%.

Evidence & confidence

Target cut signals modest concerns; no rating downgrade, so impact likely limited.

Market effects

May prompt re‑evaluation of other healthcare REITs as analysts tighten valuations.

Limited to U.S. REIT market; no broader regional effect.

Minimal global impact beyond U.S. healthcare real estate sector.

Counterpoint

The price target cut could be an over‑reaction; the Outperform rating still supports upside.

Key entities

  • Welltower Inc.

    Healthcare real estate investment trust.

  • Evercore ISI Group

    Provides the rating and price target.

Related articles

$WELLHigh

Why Welltower Stock Topped the Market on Thursday

Welltower (WELL) shares rose 1.6% after JPMorgan's Michael Mueller upgraded the stock to overweight with a $260 price target, citing strong growth prospects. The healthcare REIT's dividend yield is 1.5%, lower than peers. Mueller's upgrade was part of a broader REIT coverage reevaluation at J.P. Morgan.

$WELLMedAI 8/10

The Baby Boomer Aging Wave Has Arrived. These 4 REITs Could Benefit for a Decade

Four REITs are positioned to benefit from the aging baby boomer population. Welltower (WELL) and Ventas (VTR) focus on senior housing, while Omega Healthcare (OHI) and CareTrust (CTRE) specialize in skilled nursing. Key metrics include occupancy rates, dividend coverage, and growth guidance. WELL and VTR show strong occupancy and FFO growth, while OHI and CTRE offer higher yields with varying risks.

$WELLMedAI 8/10

Is Strong Q2 Growth Altering The Investment Case For Welltower (WELL)?

Welltower (WELL) reported Q2 2026 results with normalized FFO up 25% YoY, driven by higher revenue, better margins, and improved seniors housing occupancy. The company is investing in seniors housing assets and using its tech-driven platform for portfolio repositioning. Analysts forecast revenue of $17.5B and earnings of $3.1B by 2029, with a fair value estimate of $238.73, slightly above the current share price of $236.17.

$WELLHighAI 8/10

The Baby Boomers Are Turning 80—3 REITs Built to Cash In

Welltower (WELL), Ventas (VTR), and Omega Healthcare (OHI) are REITs benefiting from a demographic wave of aging baby boomers. Welltower reported Q2 2026 revenue of $3.54B, up 40.9% YoY, and raised FFO guidance. Ventas saw 9% YoY FFO growth and shifted focus to SHOP. Omega Healthcare improved AFFO and raised its dividend. All three companies are positioned to capitalize on increased demand for senior housing and skilled nursing facilities.